Lv1
24 积分 2026-01-21 加入
Integrative population pharmacokinetic modeling of two BCMA-targeted and one CD19-targeted CAR-T therapies using full Bayesian inference with a student’s t-based M3 censoring approach for robust handling of outliers and BLQ data
17天前
已关闭
Enhancing pharmacometric modeling with full Bayesian inference and Student’s t-Based M3 Censoring: A simulated population PK study on robust handling of outliers and censored data
17天前
已关闭
Develop adult extrapolation to pediatrics and pediatric dose optimization based on the physiological pharmacokinetic model of azithromycin
22天前
已完结
Safety, pharmacokinetics, and sex hormone suppression of LY01021 versus relugolix: A single- and multiple-dose escalation study
25天前
已完结
Guidelines for the diagnosis and treatment of refractory chronic spontaneous urticaria in China （2025 edition）
1个月前
已完结
Guideline for diagnosis and treatment of urticaria in China （2022）
1个月前
已完结
Beyond the basics: A deep dive into parameter estimation for advanced PBPK and QSP models
4个月前
已关闭
Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
4个月前
已完结
Sample size determination for bioequivalence assessment by means of confidence intervals
5个月前
已关闭
Sample size determination for bioequivalence assessment using a multiplicative model
5个月前
已完结
皖公网安备34019202002308
